Literature DB >> 6525418

Radioimmunoassay of calcitonin in normal human plasma: problems, perspectives and prospects.

H Heath, J J Body, J Fox.   

Abstract

Radioimmunoassay of calcitonin in normal human plasma is hindered by immunochemical heterogeneity in plasma, variable susceptibility of antisera to non-specific factors, limited assay sensitivity, and other problems. Many controversial points in the literature arise from these difficulties. Measurement of calcitonin after various extraction procedures yields greater consistency of results. Recent advances in calcitonin assay technology offer the promise of measuring calcitonin monomer with sufficient sensitivity to permit studies of normal calcitonin physiology and of the hormone's role in human disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6525418

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Calcitonin secretion rate in elderly normal subjects.

Authors:  M Pedrazzoni; G Ciotti; L Davoli; G Pioli; G Girasole; T Santini; M Michelini; P P Vescovi; M Passeri
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

2.  A new approach for calcitonin determination based on target cell responsiveness.

Authors:  M Zaidi; T J Chambers; B S Moonga; T Oldoni; E Passarella; R Soncini; I MacIntyre
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

3.  Meal-stimulated gastrin release and calcitonin secretion.

Authors:  M Pedrazzoni; G Ciotti; L Davoli; G Pioli; G Girasole; E Palummeri; M Passeri
Journal:  J Endocrinol Invest       Date:  1989-06       Impact factor: 4.256

4.  Stimulation of calcitonin secretion by calcium receptor activators: evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin.

Authors:  J R Lavigne; R J Zahradnik; R L Conklin; L D Lambert; M A Logan; A Parihar; J Fox
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.